Log In
BCIQ
Print this Print this
 

My5-FU (formerly OnDose)

  Manage Alerts
Collapse Summary General Information
Company Saladax Biomedical Inc.
DescriptionNanoparticle-based immunoassay measuring 5-fluorouracil (5-FU) blood plasma levels
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect 5-FU levels in blood plasma; Detect 5-FU levels in blood plasma of patients with colorectal cancer
Regulatory Designation
PartnerShanghai Fosun Pharmaceutical Group Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/11/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today